Find latest Non-Small Cell Lung Cancer videos
·
500+ videos
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
0:00
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
ASCO® 2024 Insights: "LIBRETTO-432 Trial - Adjuvant Selpercatinib vs. Placebo in Stage IB-IIIA RET+ NSCLC"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Jonathan Goldman
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Jonathan Goldman
164 views
June 14, 2024
Chapters
Introduction to RET & Selpercatinib
00:00
LIBRETTO-001 Trial & Results
01:59
Adverse Events & Management
04:03
Phase III Trial & Efficacy
06:02
LIBRETTO-432 Trial Design & Goals
07:55
Comments 0
Login to view comments.
Click here to Login